Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MACK | ELTX | CRBU | ||
| Company | Merrimack Pharmaceuticals Inc | Elicio Therapeutics Inc | Caribou Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 15.15 | 13.52 | 2.21 | ||
| High | 15.17 | 13.60 | 2.32 | ||
| Low | 15.13 | 12.20 | 2.17 | ||
| Latest | 15.13 | 12.20 | 2.29 | ||
| Change | unch | -1.35 | +0.09 | ||
| % Change | unch | -9.96% | +4.09% | ||
| Volume | 1,255,700 | 146,800 | 1,965,500 | ||
| 20-Day Average Volume | 396,880 | 121,015 | 1,274,795 | ||
| Previous Close | 15.13 | 13.55 | 2.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.95 | 10.99 | 1.97 | ||
| 20-Day Raw Stochastic | 92.47% | 58.17% | 95.43% | ||
| 20-Day Relative Strength | 74.45 | 56.72 | 63.32 | ||
| Weighted Alpha | +23.43 | +38.92 | +137.53 | ||
| Today's Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Last Month's Opinion | 80% Buy | 72% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 05/10/24 | +12.55% since 04/13/26 | +17.44% since 04/13/26 | ||
| Low | 15.10 on 05/13/24 | 10.82 on 04/14/26 | 1.97 on 04/14/26 | ||
| High | 15.16 on 05/17/24 | 13.89 on 04/17/26 | 2.32 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +3.07% since 04/17/24 | +12.44% since 03/20/26 | +22.46% since 03/20/26 | ||
| Low | 14.67 on 04/18/24 | 9.85 on 04/08/26 | 1.68 on 03/30/26 | ||
| High | 15.16 on 05/17/24 | 13.89 on 04/17/26 | 2.32 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +2.93% since 02/16/24 | +53.46% since 01/20/26 | +64.75% since 01/20/26 | ||
| Low | 14.60 on 03/12/24 | 7.37 on 01/30/26 | 1.38 on 02/02/26 | ||
| High | 15.16 on 05/17/24 | 14.93 on 03/02/26 | 2.32 on 04/20/26 | ||
| 6-Month | |||||
| %Chg | +18.02% since 11/17/23 | +28.69% since 10/20/25 | -18.79% since 10/20/25 | ||
| Low | 12.54 on 11/30/23 | 7.37 on 01/30/26 | 1.38 on 02/02/26 | ||
| High | 15.89 on 02/13/24 | 14.93 on 03/02/26 | 3.54 on 11/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 223,742 | 224,431 | 221,299 | ||
| Shares Outstanding, K | 14,788 | 18,396 | 96,637 | ||
| Annual Sales | 0 | 0 | 11,160,000 | ||
| Annual Net Income | -1,180,000 | -39,570,000 | -148,130,000 | ||
| Last Quarter Sales | 0 | 0 | 3,940,000 | ||
| Last Quarter Net Income | -240,000 | -7,720,000 | -26,490,000 | ||
| 60-Month Beta | 1.45 | 1.11 | 2.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 05/15/24 | -0.49 on 03/12/26 | -0.28 on 03/05/26 | ||
| Latest Earnings Date | 08/01/24 | 05/12/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 05/30/17 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||